Watermark
Watermark

Clinical Trials

We are committed to bringing patients worldwide better treatment options.

We are recruiting for clinical trials across a wide range of therapeutic indications, including lymphoma, liver cancers, lung cancers, gastric cancers, breast cancers, and more.

 

Questions about a clinical trial?

If you are a patient or a health care provider and would like more information about a clinical trial, please contact our research team.

Search Clinical Trials

  • Age
  • Available Documents
  • Patient Level Data Anonymized patient level data for select studies available to qualified scientific researchers
  • No
  • Phases Phase 1: A step in clinical research to focus on the safety of a drug and how it works in the body.

Phase 2: A step in clinical research to gather data on whether a drug works in people who have a certain condition or disease.

Phase 3: A step in clinical research that gathers more information about a drug’s safety and if it works in people.

Phase 4: A step in clinical research after regulatory authorities have approved a drug for marketing.

N/A: For observational studies or interventional studies that do not support drug development.
  • Results
  • Sex In this context, a person’s sex refers to that person’s assigned sex at birth. This has been the case historically; however, there is growing understanding in the healthcare community that this definition excludes certain segments of the population and should be expanded, where possible, to account for gender identity as well. BeiGene recognizes the importance of making clinical trials accessible to all groups of people and is committed to promoting inclusive research.
  • Study Status Recruiting: The study is open to enrollment for qualified participants.

Will be Recruiting: The study has not yet opened enrollment for qualified participants.

Recruitment Complete: The study is ongoing, and participants are receiving an intervention or being examined, but new potential participants are not currently being recruited or enrolled.

Completed: The study has ended normally, and participants are no longer receiving an intervention or being examined.

Other: All other study statuses such as withdrawn, canceled, or terminated.
  • Study Type <strong>Expanded Access:</strong> A way for patients with serious diseases or conditions who cannot participate in a clinical study to gain access to a medical product that has not been approved by regulatory authorities. Also called compassionate use.

<strong>Interventional:</strong> A type of clinical trial in which participants are assigned to groups that receive one or more treatment or study drug (intervention).

<strong>Observational:</strong> A type of clinical study in which participants may receive diagnostic or study drugs but the study investigator does not assign participants to a a specific intervention or treatment.
  • Vaccine Studies
Clear

Search Results

Study ID
Phase
Condition(s)
Status
Sex
Age Range

BGB-A317-A1217-301
3

Non Small Cell Lung Cancer

Terminated

All

18 Years / N/A

BGB-A317-A1217-301

Terminated

Phase

3

Condition

Non Small Cell Lung Cancer

Sex

All

Age

18 Years / N/A


BGB-290-202
2

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Terminated

Male

18 Years / N/A

BGB-290-202

Terminated

Phase

2

Condition

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Sex

Male

Age

18 Years / N/A


BGB-900-101
1/2

Advanced Solid Tumors

Terminated

All

18 Years / N/A

BGB-900-101

Terminated

Phase

1/2

Condition

Advanced Solid Tumors

Sex

All

Age

18 Years / N/A


BGB-A317-B167-101
1

Solid Tumor

Terminated

All

18 Years / N/A

BGB-A317-B167-101

Terminated

Phase

1

Condition

Solid Tumor

Sex

All

Age

18 Years / N/A


BGB-A317-Sitravatinib-203
2

Esophageal Squamous Cell Carcinoma

Terminated

All

18 Years / N/A

BGB-A317-Sitravatinib-203

Terminated

Phase

2

Condition

Esophageal Squamous Cell Carcinoma

Sex

All

Age

18 Years / N/A


BGB-A317-Sitravatinib-301
3

Non-Small Cell Lung Cancer (NSCLC)

Terminated

All

18 Years / N/A

BGB-A317-Sitravatinib-301

Terminated

Phase

3

Condition

Non-Small Cell Lung Cancer (NSCLC)

Sex

All

Age

18 Years / N/A


BGB-23339-102
1

Healthy Volunteers

Withdrawn

All

18 Years / 55 Years

BGB-23339-102

Withdrawn

Phase

1

Condition

Healthy Volunteers

Sex

All

Age

18 Years / 55 Years


BGB-A317-B167-102
1

Solid Tumors

Withdrawn

All

18 Years / N/A

BGB-A317-B167-102

Withdrawn

Phase

1

Condition

Solid Tumors

Sex

All

Age

18 Years / N/A